A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double (MYC and BCL2) Expression. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.